Health Trials

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer

ConditionsPancreas CancerPancreas NeoplasmPancreas DiseasePancreas AdenocarcinomaSurgeryChemotherapy EffectQuality of LifeLocally Advanced Pancreatic AdenocarcinomaBorderline Resectable Pancreatic Adenocarcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUmeå University

About this trial

This study aims to assess overall survival, quality of life and resection rates in locally advanced pancreatic cancer

Eligibility criteria

Qualifiers

Confirmed or suspected invasive pancreatic primary tumor

Tumor classified as borderline resectable or locally advanced disease according to NCCN guidelines

Disqualifiers

Suspected endocrine tumor

Suspected non-pancreatic periampullary tumor

Distant metastasis

Age < 18 years

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Umeå University

Lead sponsor

University Hospital, Linkoeping

Collaborator

Lund University Hospital

Collaborator

Sahlgrenska University Hospital

Collaborator

Karolinska University Hospital

Collaborator

University Hospital, Umeå

Collaborator

Source ClinicalTrials.gov